Bioneer Corporation (KOSDAQ:064550)
South Korea · Delayed Price · Currency is KRW 6,860.00
+50.00 (0.73%)
Nov 2, 2026, 3:30 PM KST
Bioneer Market Cap
Bioneer has a market cap or net worth of 177.06 billion as of October 30, 2026. It is the 23,229th most valuable company in the world and the 884th biggest in South Korea. Its market cap has decreased by 55.74% in one year.
Market Cap
177.06B
Enterprise Value
210.92B
Revenue
345.88B
Global Rank
Country Rank
#884 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since December 29, 2005, Bioneer's market cap has increased from 157.77B to 177.06B, an increase of 12.23%. That is a compound annual growth rate of 0.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 177.06B | -46.20% |
| Dec 30, 2025 | 329.08B | -32.36% |
| Dec 30, 2024 | 486.52B | -43.39% |
| Dec 28, 2023 | 859.48B | 13.27% |
| Dec 29, 2022 | 758.82B | -39.51% |
| Dec 30, 2021 | 1.25T | 181.19% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MEDIPOST | 316.20B |
| SillaJen | 279.88B |
| Genomictree | 244.71B |
| HLB Therapeutics | 219.91B |
| GC Genome | 215.22B |
| Helixmith | 170.37B |
| NeoImmuneTech | 155.82B |
| GC Cell | 151.77B |